GSK's HIV drugs get green light from Scotland
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has fared well with the Scottish Medicines Consortium (SMC) this month, gaining acceptance for two of its antiretrovirals (ARVs) for use on the Scottish NHS.